Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins

RTTNews | Před 410 dny
Stocktwits
Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins

(RTTNews) - Israeli-based foodtech company Imagindairy and Ginkgo Bioworks (DNA) announced Tuesday a new partnership with the aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.

This collaboration will leverage Ginkgo Protein Expression Services and Imagindairy's process development and scale-up expertise to accelerate the development of functional non-whey dairy proteins.

This is a multi-year program, funded in part by a joint grant from the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

Imagindairy and Ginkgo have partnered to design an optimized organism capable of cost-effectively producing non-whey dairy proteins. This will allow Imagindairy to remain focused on whey protein production and commercialization while accelerating time to market of non-whey proteins.

Značky : DNA
Stocktwits
read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | Před 394 dny
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews | Před 486 dny
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | Před 1020 dny
U.S. Dollar Declines On Trade Deal Optimism

U.S. Dollar Declines On Trade Deal Optimism

The U.S. dollar weakened against its major counterparts in the New York session on Friday as investors looked ahead to discussions between the U.S. and China scheduled for this weekend.
RTTNews | Před 1 dnem
Swiss Market Ends On Positive Note

Swiss Market Ends On Positive Note

The Swiss market closed higher on Friday as easing concerns about trade tensions following the announcement of a trade deal between the U.S. and U.K., and upcoming talks between U.S. and China helped keep the mood positive.
RTTNews | Před 1 dnem
Nástroje
Ekonomický kalendář
Market Hours
Interest Rates
Holidays Calendar
Forexový trh
Forex volatilita
Korelace Forexu
Novinky na Forexu
forex analysis
COT údaje
Likvidita
Forex kalkulačky
Forex Tepelná mapa
Indicators Heatmap
Komunita
Komunita
Systémy
Nejpopulárnější systémy
Strategie
Soutěže
Forexové grafy
Forexový sentiment
Indikátor Outlook
Recenze
Brokeři
Prop Trading Firms
Služby VPS
Poskytovatelé signálu
Služby programování EA
Affiliate Programs
Služby PAMM Brokera
Služby slevového programu
Obchodní platformy
Odborní poradci
Kryptoburzy
Trading Courses
Brokeři
Forex Spready
Nabídky Forex brokerů
Swapy Forex brokerů
Objem brokera Forexu
Propagační akce Forex Brokera Press Release
Platforma
Miniaplikace
Funkce
API
RSS
Stock Portfolio
Affiliate Software
Rozšířené grafy
Podpora
Faq
Pomoc
Kontaktuj nás
Nahlásit chybu!
O
Blog
& copy; 2025 Myfxbook Ltd. Všechna práva vyhrazena.
UPOZORNĚNÍ NA VYSOKÉ RIZIKO: Obchodování s devizami přináší vysokou úroveň rizika, které nemusí být vhodné pro všechny investory. Páka vytváří další rizika a ztráty. Než se rozhodnete obchodovat s devizami, důkladně zvažte své investiční cíle, úroveň zkušeností a toleranci vůči riziku. Můžete přijít o část nebo všechny své počáteční investice. Neinvestujte peníze, které si nemůžete dovolit ztratit. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Všechny údaje a informace jsou poskytovány "tak, jak jsou". pouze pro informační účely a nejsou určeny pro obchodní účely nebo rady. Výkonnost v minulosti neznamená výkonnost v budoucnosti.